OS Therapies Incorporated OSTX
1.66
0.00
0.00%
as of 25 Sep
- Market cap
- $77.7M
- P/E
- 0.0×
Follow OSTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
0.03 | 1.20 | 0.03 | 0.08 |
Net Debt/EBITDA |
0.01 | 1.03 | 0.02 | (3.09) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2,032.53% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.59) |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.50 | 0.82 | 0.38 | 0.59 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 614.26% | 65.34% | 38.08% | 0.00% | |
| (464.58%) | (281.34%) | (1,211.23%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
251.58% | (977.97%) | 33.10% | 113.14% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.95 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(0.49) | (1.05) | (0.55) | (0.76) |
Cash per Share |
0.01 | 0.80 | 0.01 | 0.03 |
Shareholders Equity per Share |
(0.17) | 0.12 | (4.42) | (3.52) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.17) | 0.12 | (4.42) | (3.52) |
Free Cash Flow |
(14.24) | (7.28) | (3.01) | (3.79) |
Working Capital |
(11.43) | 0.91 | (23.92) | (5.65) |
Net Current Asset Value |
(11.53) | 0.81 | (24.02) | (17.57) |
| Other line items | ||||
Quick Ratio |
0.02 | 1.20 | 0.00 | 0.03 |
Depreciation/Fixed assets |
560.28 | 269.53 | 327.25 | 93.68 |
Cash ROIC |
299.49% | (114.86%) | 12.57% | 54.06% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.49) | (1.05) | (0.55) | (0.76) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
5.80 | 2.19 | 1.97 | — |
Average Assets |
6.19 | 3.17 | 0.65 | — |
Average Common Equity |
(4.68) | (13.64) | (20.79) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates